Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 3
1951 5
1954 1
1955 3
1956 3
1957 3
1958 2
1959 1
1960 2
1962 9
1963 5
1964 3
1965 5
1966 2
1967 1
1968 2
1969 3
1970 5
1971 3
1972 6
1973 4
1974 4
1975 10
1976 6
1977 11
1978 11
1979 2
1980 9
1981 6
1982 11
1983 7
1984 10
1985 12
1986 16
1987 23
1988 18
1989 28
1990 23
1991 32
1992 34
1993 28
1994 33
1995 41
1996 53
1997 53
1998 75
1999 99
2000 121
2001 149
2002 149
2003 232
2004 242
2005 231
2006 268
2007 324
2008 333
2009 346
2010 400
2011 444
2012 452
2013 492
2014 497
2015 493
2016 511
2017 525
2018 515
2019 525
2020 568
2021 601
2022 234
Text availability
Article attribute
Article type
Publication date

Search Results

8,331 results
Results by year
Filters applied: . Clear all
Page 1
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Janjigian YY, Kawazoe A, Yañez P, Li N, Lonardi S, Kolesnik O, Barajas O, Bai Y, Shen L, Tang Y, Wyrwicz LS, Xu J, Shitara K, Qin S, Van Cutsem E, Tabernero J, Li L, Shah S, Bhagia P, Chung HC. Janjigian YY, et al. Among authors: chung hc. Nature. 2021 Dec;600(7890):727-730. doi: 10.1038/s41586-021-04161-3. Epub 2021 Dec 15. Nature. 2021. PMID: 34912120 Clinical Trial.
New-onset IgG autoantibodies in hospitalized patients with COVID-19.
Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro J, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James JA, Kim PS, Meyer NJ, Nadeau KC, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Luning Prak ET, Utz PJ. Chang SE, et al. Among authors: chung hr. Nat Commun. 2021 Sep 14;12(1):5417. doi: 10.1038/s41467-021-25509-3. Nat Commun. 2021. PMID: 34521836 Free PMC article.
COVID-19 vaccine induced rhabdomyolysis: Case report with literature review.
Nassar M, Chung H, Dhayaparan Y, Nyein A, Acevedo BJ, Chicos C, Zheng D, Barras M, Mohamed M, Alfishawy M, Nso N, Rizzo V, Kimball E. Nassar M, et al. Among authors: chung h. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102170. doi: 10.1016/j.dsx.2021.06.007. Epub 2021 Jun 15. Diabetes Metab Syndr. 2021. PMID: 34186348 Free PMC article. Review. No abstract available.
Joint single-cell measurements of nuclear proteins and RNA in vivo.
Chung H, Parkhurst CN, Magee EM, Phillips D, Habibi E, Chen F, Yeung BZ, Waldman J, Artis D, Regev A. Chung H, et al. Nat Methods. 2021 Oct;18(10):1204-1212. doi: 10.1038/s41592-021-01278-1. Epub 2021 Oct 4. Nat Methods. 2021. PMID: 34608310 Free PMC article.
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Chung H, et al. BMJ. 2021 Aug 20;374:n1943. doi: 10.1136/bmj.n1943. BMJ. 2021. PMID: 34417165 Free PMC article.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, Lee KW, Omori T, Shitara K, Sakuramoto S, Chung IJ, Yamaguchi K, Kato K, Sym SJ, Kadowaki S, Tsuji K, Chen JS, Bai LY, Oh SY, Choda Y, Yasui H, Takeuchi K, Hirashima Y, Hagihara S, Boku N. Kang YK, et al. Among authors: chung hc. Lancet Oncol. 2022 Feb;23(2):234-247. doi: 10.1016/S1470-2045(21)00692-6. Epub 2022 Jan 11. Lancet Oncol. 2022. PMID: 35030335 Clinical Trial.
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing.
Lin YT, Chiang CL, Hung JY, Lee MH, Su WC, Wu SY, Wei YF, Lee KY, Tseng YH, Su J, Chung HP, Lin CB, Ku WH, Chiang TS, Chiu CH, Shih JY. Lin YT, et al. Among authors: chung hp. Eur J Cancer. 2021 Oct;156:1-11. doi: 10.1016/j.ejca.2021.06.043. Epub 2021 Aug 13. Eur J Cancer. 2021. PMID: 34392186 Free article.
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆.
Niu J, Maurice-Dror C, Lee DH, Kim DW, Nagrial A, Voskoboynik M, Chung HC, Mileham K, Vaishampayan U, Rasco D, Golan T, Bauer TM, Jimeno A, Chung V, Chartash E, Lala M, Chen Q, Healy JA, Ahn MJ. Niu J, et al. Among authors: chung hc. Ann Oncol. 2022 Feb;33(2):169-180. doi: 10.1016/j.annonc.2021.11.002. Epub 2021 Nov 18. Ann Oncol. 2022. PMID: 34800678 Free article. Clinical Trial.
Adrenal hemangioblastoma.
Koo JY, Lee KH, Choi JH, Chung HS, Choi C. Koo JY, et al. Among authors: chung hs. J Pathol Transl Med. 2022 May;56(3):161-166. doi: 10.4132/jptm.2021.12.28. Epub 2022 Feb 28. J Pathol Transl Med. 2022. PMID: 35209700 Free article.
8,331 results